PHASE III ARCADIA 1 and 2 Trial Primary Results Published in The Lancet: Galderma』s Nemolizumab Improves Key Aspects of Atopic Dermatitis – Itch, Skin Lesions and Sleep Disturbance
ZUG, Switzerland--(BUSINESS WIRE)--Galderma today announced that full results from the phase III ARCADIA 1 and 2 clinical trials in atopic dermatitis were published in The Lancet.1The tria......
